CompletedPhase 4NCT02297100

Intravesicular Onabotulinumtoxin A in Interstitial Cystitis

Studying Interstitial cystitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Wake Forest University Health Sciences
Principal Investigator
Robert J Evans, M.D.
Wake Forest University Health Sciences
Intervention
Onabotulinumtoxin A(drug)
Enrollment
27 enrolled
Eligibility
18-80 years · FEMALE
Timeline
20142018

Study locations (1)

Collaborators

Allergan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02297100 on ClinicalTrials.gov

Other trials for Interstitial cystitis

Additional recruiting or active studies for the same condition.

See all trials for Interstitial cystitis

← Back to all trials